Skip to content
by Legal Desire
14 February 2025

Clifford Chance advises dsm-firmenich on the sale of its stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion

M&A Agriculture & Food Expected to close

Advising firms

Deal team

23 lawyers named
LawyerFirmSeniorityPracticeOffice
Gregory Crookes Lead Clifford Chance Not stated Not stated Not stated
Stephanie Horowitz Lead Clifford Chance Not stated Not stated Not stated
Pieter Leefers Lead Clifford Chance Not stated Not stated Not stated
Sabine van den Heuvel Lead Clifford Chance Not stated Not stated Not stated
Chris in 't Veld Lead Clifford Chance Not stated Not stated Not stated
Marc Besen Clifford Chance Not stated Not stated Not stated
Jurre Jurriëns Clifford Chance Not stated Not stated Not stated
Fiorri Michael Clifford Chance Not stated Antitrust Not stated
Gunnar Sachs Clifford Chance Not stated Corporate Regulatory – Healthcare, Life Science & Chemicals Not stated
Kathrin Schroeder-Finckh Clifford Chance Not stated Corporate Regulatory – Healthcare, Life Science & Chemicals Not stated
Claudia Milbradt Clifford Chance Not stated Intellectual Property Not stated
Nicolas Hohn-Hein Clifford Chance Not stated Intellectual Property Not stated
Floris van de Bult Clifford Chance Not stated Employment Not stated
Florence Aubonnet Clifford Chance Not stated Employment Not stated
Merle van den Berg Clifford Chance Not stated Employment Not stated
Alexander Stemmler Clifford Chance Not stated Employment Not stated
Iga Mamczarz Clifford Chance Not stated Employment Not stated
Wijnanda Rutten Clifford Chance Not stated Pensions Not stated
Michiel Sunderman Clifford Chance Not stated Tax Not stated
Alec Sanderson Clifford Chance Not stated Tax Not stated
Orsolya Gondos Clifford Chance Not stated Tech//Digital Not stated
Tamlin Higgins Clifford Chance Not stated Tech//Digital Not stated
Robert Bulte Clifford Chance Not stated Corporate Not stated

Stated terms

Stated value
EUR 1.50bn (€1.5 billion)
What the figure measures
Total transaction value
Client
dsm-firmenichSell-side
Counterparties
Novonesis (Buy-side)